HomeCompareTWSI vs MRK

TWSI vs MRK: Dividend Comparison 2026

TWSI yields 3448.28% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TWSI wins by $1721569626570.50M in total portfolio value
10 years
TWSI
TWSI
● Live price
3448.28%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1721569626570.53M
Annual income
$1,628,658,888,804,024,000.00
Full TWSI calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — TWSI vs MRK

📍 TWSI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTWSIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TWSI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TWSI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TWSI
Annual income on $10K today (after 15% tax)
$293,103.45/yr
After 10yr DRIP, annual income (after tax)
$1,384,360,055,483,420,400.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, TWSI beats the other by $1,384,360,055,483,419,600.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TWSI + MRK for your $10,000?

TWSI: 50%MRK: 50%
100% MRK50/50100% TWSI
Portfolio after 10yr
$860784813285.28M
Annual income
$814,329,444,402,012,500.00/yr
Blended yield
94.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TWSI
No analyst data
Altman Z
-24.2
Piotroski
0/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TWSI buys
0
MRK buys
0
No recent congressional trades found for TWSI or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTWSIMRK
Forward yield3448.28%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$1721569626570.53M$30.7K
Annual income after 10y$1,628,658,888,804,024,000.00$950.29
Total dividends collected$1715190513351.49M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TWSI vs MRK ($10,000, DRIP)

YearTWSI PortfolioTWSI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$355,528$344,827.59$11,192$351.54+$344.3KTWSI
2$11,837,958$11,457,543.87$12,524$392.70+$11.83MTWSI
3$369,209,075$356,542,459.20$14,015$438.65+$369.20MTWSI
4$10,787,625,565$10,392,571,854.67$15,682$489.96+$10787.61MTWSI
5$295,329,928,063$283,787,168,709.35$17,547$547.23+$295329.91MTWSI
6$7,576,904,991,895$7,260,901,968,866.71$19,632$611.16+$7576904.97MTWSI
7$182,204,244,270,481$174,096,955,929,154.22$21,963$682.53+$182204244.25MTWSI
8$4,107,635,992,739,046$3,912,677,451,369,630.00$24,571$762.18+$4107635992.71MTWSI
9$86,832,465,202,340,210$82,437,294,690,109,440.00$27,486$851.08+$86832465202.31MTWSI
10$1,721,569,626,570,528,000$1,628,658,888,804,024,000.00$30,745$950.29+$1721569626570.50MTWSI

TWSI vs MRK: Complete Analysis 2026

TWSIStock

TriStar Wellness Solutions, Inc. develops, markets, and sells wound care products. The company also offers skincare and other products under the Beaute de Maman name for pregnant and nursing women; bleeding and wound management products for surgical, health care, consumer, and military markets; and develops and markets Delivery Devise with Invertible Diaphragm, which is a medical applicator for delivering medicants and internal devices within the body without producing injury or damage. In addition, it develops over-the-counter itch suppression products; and develops, manufactures, and markets wound care and infection control medical devices. The company was formerly known as BioPack Environmental Solutions, Inc. and changed its name to TriStar Wellness Solutions, Inc. in January 2013. TriStar Wellness Solutions, Inc. is based in Portland, Oregon. On January 15, 2016, TriStar Wellness Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Oregon.

Full TWSI Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this TWSI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TWSI vs SCHDTWSI vs JEPITWSI vs OTWSI vs KOTWSI vs MAINTWSI vs JNJTWSI vs ABBVTWSI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.